Silver nanoparticles
Side effects
Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|---|
| 1 | ||||
| Muscle contracture | Muscle contracture | x | ||
| Erythema multiforme | Erythema multiforme | x | ||
| Dermatitis | Rash | x | ||
| Rash | Rash | x | ||
| Leukopenia | Leukopenia | x | ||
| Tubulointerstitial nephritis | Nephritis interstitial | x | ||
| Partner stress | Separation | x | ||
| Burning sensation | Burning sensation | x | ||
| Skin necrosis | Skin necrosis | x | ||
| Skin exfoliation | Skin necrosis | x | ||
| Skin discolouration | Skin discolouration | x | ||
| Sepsis | Sepsis | x | ||
| Bacterial disease carrier | Bacterial colonisation | x | ||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Burns third degree | x | |||
| Wound sepsis | x | |||
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
